Literature DB >> 17553871

Vpr cytopathicity independent of G2/M cell cycle arrest in human immunodeficiency virus type 1-infected CD4+ T cells.

Diane L Bolton1, Michael J Lenardo.   

Abstract

The mechanism of CD4(+) T-cell depletion in human immunodeficiency virus type 1 (HIV-1)-infected individuals remains unknown, although mounting evidence suggests that direct viral cytopathicity contributes to this loss. The HIV-1 Vpr accessory protein causes cell death and arrests cells in the G(2)/M phase; however, the molecular mechanism underlying these properties is not clear. Mutation of hydrophobic residues on the surface of its third alpha-helix disrupted Vpr toxicity, G(2)/M arrest induction, nuclear localization, and self-association, implicating this region in multiple Vpr functions. Cytopathicity by virion-delivered mutant Vpr protein correlated with G(2)/M arrest induction but not nuclear localization or self-association. However, infection with whole virus encoding these Vpr mutants did not abrogate HIV-1-induced cell killing. Rather, mutant Vpr proteins that are impaired for G(2)/M block still prevented infected cell proliferation, and this property correlated with the death of infected cells. Chemical agents that inhibit infected cells from entering G(2)/M also did not reduce HIV-1 cytopathicity. Combined, these data implicate Vpr in HIV-1 killing through a mechanism involving inhibiting cell division but not necessarily in G(2)/M. Thus, the hydrophobic region of the third alpha-helix of Vpr is crucial for mediating G(2)/M arrest, nuclear localization, and self-association but dispensable for HIV-1 cytopathicity due to residual cell proliferation blockade mediated by a separate region of the protein.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17553871      PMCID: PMC1951439          DOI: 10.1128/JVI.00122-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  75 in total

Review 1.  The dynamics of CD4+ T-cell depletion in HIV disease.

Authors:  J M McCune
Journal:  Nature       Date:  2001-04-19       Impact factor: 49.962

2.  Measurement of molecular interactions in living cells by fluorescence resonance energy transfer between variants of the green fluorescent protein.

Authors:  R M Siegel; F K Chan; D A Zacharias; R Swofford; K L Holmes; R Y Tsien; M J Lenardo
Journal:  Sci STKE       Date:  2000-06-27

3.  Induction of apoptosis by the Vpr protein of human immunodeficiency virus type 1 occurs independently of G(2) arrest of the cell cycle.

Authors:  M Nishizawa; M Kamata; T Mojin; Y Nakai; Y Aida
Journal:  Virology       Date:  2000-10-10       Impact factor: 3.616

4.  Vpr protein of human immunodeficiency virus type 1 binds to 14-3-3 proteins and facilitates complex formation with Cdc25C: implications for cell cycle arrest.

Authors:  Tomoshige Kino; Alexander Gragerov; Antonio Valentin; Maria Tsopanomihalou; Galina Ilyina-Gragerova; Rebecca Erwin-Cohen; George P Chrousos; George N Pavlakis
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

5.  Functional and structural characterization of synthetic HIV-1 Vpr that transduces cells, localizes to the nucleus, and induces G2 cell cycle arrest.

Authors:  P Henklein; K Bruns; M P Sherman; U Tessmer; K Licha; J Kopp; C M de Noronha; W C Greene; V Wray; U Schubert
Journal:  J Biol Chem       Date:  2000-10-13       Impact factor: 5.157

6.  Dynamic disruptions in nuclear envelope architecture and integrity induced by HIV-1 Vpr.

Authors:  C M de Noronha; M P Sherman; H W Lin; M V Cavrois; R D Moir; R D Goldman; W C Greene
Journal:  Science       Date:  2001-11-02       Impact factor: 47.728

7.  Comparison of cell cycle arrest, transactivation, and apoptosis induced by the simian immunodeficiency virus SIVagm and human immunodeficiency virus type 1 vpr genes.

Authors:  Y Zhu; H A Gelbard; M Roshal; S Pursell; B D Jamieson; V Planelles
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

8.  Regulation of cell cycle and apoptosis by human immunodeficiency virus type 1 Vpr.

Authors:  T Fukumori; H Akari; A Yoshida; M Fujita; A H Koyama; S Kagawa; A Adachi
Journal:  Microbes Infect       Date:  2000-07       Impact factor: 2.700

Review 9.  T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock.

Authors:  M D Hazenberg; D Hamann; H Schuitemaker; F Miedema
Journal:  Nat Immunol       Date:  2000-10       Impact factor: 25.606

10.  Cytopathic killing of peripheral blood CD4(+) T lymphocytes by human immunodeficiency virus type 1 appears necrotic rather than apoptotic and does not require env.

Authors:  Michael J Lenardo; Sara B Angleman; Viengngeun Bounkeua; Joseph Dimas; Melody G Duvall; Moses B Graubard; Felicita Hornung; Marianne C Selkirk; Christina K Speirs; Carol Trageser; Jan O Orenstein; Diane L Bolton
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

View more
  27 in total

Review 1.  Defining the roles for Vpr in HIV-1-associated neuropathogenesis.

Authors:  Tony James; Michael R Nonnemacher; Brian Wigdahl; Fred C Krebs
Journal:  J Neurovirol       Date:  2016-04-07       Impact factor: 2.643

2.  Molecular insight into how HIV-1 Vpr protein impairs cell growth through two genetically distinct pathways.

Authors:  Claire Maudet; Matthieu Bertrand; Erwann Le Rouzic; Hichem Lahouassa; Diana Ayinde; Sébastien Nisole; Caroline Goujon; Andrea Cimarelli; Florence Margottin-Goguet; Catherine Transy
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

3.  Protein kinase A phosphorylation activates Vpr-induced cell cycle arrest during human immunodeficiency virus type 1 infection.

Authors:  R Anthony Barnitz; Fengyi Wan; Vinay Tripuraneni; Diane L Bolton; Michael J Lenardo
Journal:  J Virol       Date:  2010-04-14       Impact factor: 5.103

4.  Human polyomavirus JC small regulatory agnoprotein forms highly stable dimers and oligomers: implications for their roles in agnoprotein function.

Authors:  A Sami Saribas; Buenafe T Arachea; Martyn K White; Ronald E Viola; Mahmut Safak
Journal:  Virology       Date:  2011-09-13       Impact factor: 3.616

5.  JC virus agnoprotein enhances large T antigen binding to the origin of viral DNA replication: evidence for its involvement in viral DNA replication.

Authors:  A Sami Saribas; Martyn K White; Mahmut Safak
Journal:  Virology       Date:  2012-07-27       Impact factor: 3.616

6.  Human immunodeficiency virus type 1 Vpr: oligomerization is an essential feature for its incorporation into virus particles.

Authors:  Narasimhan J Venkatachari; Leah A Walker; Oznur Tastan; Thien Le; Timothy M Dempsey; Yaming Li; Naveena Yanamala; Alagarsamy Srinivasan; Judith Klein-Seetharaman; Ronald C Montelaro; Velpandi Ayyavoo
Journal:  Virol J       Date:  2010-06-07       Impact factor: 4.099

7.  HIV-1 Vpr oligomerization but not that of Gag directs the interaction between Vpr and Gag.

Authors:  Joëlle V Fritz; Denis Dujardin; Julien Godet; Pascal Didier; Jan De Mey; Jean-Luc Darlix; Yves Mély; Hugues de Rocquigny
Journal:  J Virol       Date:  2009-11-18       Impact factor: 5.103

8.  Endogenous HIV-1 Vpr-mediated apoptosis and proteome alteration of human T-cell leukemia virus-1 transformed C8166 cells.

Authors:  Fang He; Yaoying Zeng; Xiaoping Wu; Yuhua Ji; Xianhui He; Thomas Andrus; Tuofu Zhu; Tong Wang
Journal:  Apoptosis       Date:  2009-10       Impact factor: 4.677

9.  HIV-1 causes CD4 cell death through DNA-dependent protein kinase during viral integration.

Authors:  Arik Cooper; Mayra García; Constantinos Petrovas; Takuya Yamamoto; Richard A Koup; Gary J Nabel
Journal:  Nature       Date:  2013-06-05       Impact factor: 49.962

10.  HIV-1 Gag Recruits Oligomeric Vpr via Two Binding Sites in p6, but Both Mature p6 and Vpr Are Rapidly Lost upon Target Cell Entry.

Authors:  Madushi Wanaguru; Kate N Bishop
Journal:  J Virol       Date:  2021-08-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.